Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Sun Pharma Advanced Research Company Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.

Key Information

Market Cap

51099234304

Current Price

157.46

52 Week Range

109.3 - 241.0

Previous Close

160.87

Open

160.87

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

17/B, Mahal Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai, 400093, India

Phone

+91-22664-55645

Fax

+91-22664-55685

Website

https://www.sparc.life

Financials

Day Low

156.8

Day High

162.87

Dividend Yield

PE Ratio

Earnings Per Share

-10.55

Beta

0.346

EBITDA

-3252178944

Book Value

-6.685

EPS

Company Officers

Name	Title	Age	Year Born
Mr. Anilkumar Raghavan	Chief Executive Officer	56	1968
Mr. Anup Rathi	Chief Financial Officer	-	-
Dr. Nitin Dharmadhikari	Chief Operating Officer	62	1962
Mr. Jaydeep Issrani	Senior General Manager of Business Development, Corporate Communication & Investor Relations	-	-
Ms. Kajal K. Damania	Company Secretary & Compliance Officer	-	-
Ms. Shanta Gupta	Chief Human Resource Officer	-	-
Mr. Siu-Long Yao	Head Clinical Development	-	-
Dr. Nitin K. Damle Ph.D.	Chief Innovation Officer	-	-
Dr. Yashoraj Zala	Head of Drug Delivery Systems	-	-
Dr. Vikram K. Ramanathan	Head of Drug Discovery & Preclinical Development	-	-